References

Publication Details

1.
McEwen A, Hajek P, McRobbie H, West R. Manual of Smoking Cessation: A Guide for Counsellors and Practitioners. Oxford: Blackwell Publishing; 2006.
2.
Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004;99:29–38. 10.1111/j.1360-0443.2004.00540.x. [PubMed: 14678060] [CrossRef]
3.
Ferguson J, Bauld L, Chesterman J, Judge K. The English smoking treatment services: one-year outcomes. Addiction 2005;100(Suppl. 2):59–69. 10.1111/j.1360-0443.2005.01028.x. [PubMed: 15755262] [CrossRef]
4.
Bauld L, Judge K, Platt S. Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tob Control 2007;16:400–4. 10.1136/tc.2007.021626. [PMC free article: PMC2807194] [PubMed: 18048617] [CrossRef]
5.
Hiscock R, Bauld L, Amos A, Fidler JA, Munafo M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci 2012;1248:107–23. 10.1111/j.1749-6632.2011.06202.x. [PubMed: 22092035] [CrossRef]
6.
Fidler JA, Shahab L, West O, Jarvis MJ, McEwen A, Stapleton JA, et al. The smoking toolkit study: a national study of smoking and smoking cessation in England. BMC Public Health 2001;11:479. 10.1186/1471-2458-11-479. [PMC free article: PMC3145589] [PubMed: 21682915] [CrossRef]
7.
Bryant J, Bonevski B, Paul C, McElduff P, Attia J. A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction 2011;106:1568–85. 10.1111/j.1360-0443.2011.03467.x. [PubMed: 21489007] [CrossRef]
8.
Michie S, Rumsey N, Fussell S, Hardeman W, Johnston M, Newman S, et al. Improving Health – Changing Behaviour: NHS Health Trainer Handbook. London: Department of Health and British Psychological Society; 2008.
9.
Michie S, Jochelson K, Markham WA, Bridle C. Low income groups and behaviour change interventions: a review of intervention content and effectiveness. J Epidemiol Community Health 2009;63:250–6. 10.1136/jech.2008.078725. [PubMed: 19386612] [CrossRef]
10.
Beard E, Vangeli E, Michie S, West R. The use of nicotine replacement therapy for smoking reduction and temporary abstinence: an interview study. Nicotine Tob Res 2012;14:849–56. 10.1093/ntr/ntr297. [PubMed: 22193570] [CrossRef]
11.
Black A, Beard E, Brown J, Fidler J, West R. Beliefs about the harms of long-term use of nicotine replacement therapy: perceptions of smokers in England. Addiction 2012;107:2037–42. 10.1111/j.1360-0443.2012.03955.x. [PubMed: 22632274] [CrossRef]
12.
Beard E, McDermott M, McEwen A, West R. Beliefs of stop smoking practitioners in United kingdom on the use of nicotine replacement therapy for smoking reduction. Nicotine Tob Res 2012;14:639–47. 10.1093/ntr/ntr260. [PubMed: 22180579] [CrossRef]
13.
Lindson N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev 2010;11:CD008033. 10.1002/14651858.CD008033. [PubMed: 20238361] [CrossRef]
14.
Shiffman S, Hughes JR, Ferguson SG, Pillitteri JL, Gitchell JG, Burton SL. Smokers’ interest in using nicotine replacement to aid smoking reduction. Nicotine Tob Res 2007;9:1177–82. 10.1080/14622200701648441. [PubMed: 17978992] [CrossRef]
15.
Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D. ‘Cut down to quit’ with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 2008;12(2). [PubMed: 18093448]
16.
Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 2011;106:2110–21. 10.1111/j.1360-0443.2011.03565.x. [PubMed: 21752135] [CrossRef]
17.
Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol 2004;72:371–81. 10.1037/0022-006X.72.3.371. [PubMed: 15279521] [CrossRef]
18.
Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction 2005;100:1074–89. 10.1111/j.1360-0443.2005.01174.x. [PMC free article: PMC1419056] [PubMed: 16042638] [CrossRef]
19.
Haasova M, Warren FC, Ussher M, Janse Van Rensburg K, Faulkner G, Cropley M, et al. The acute effects of physical activity on cigarette cravings: systematic review and meta-analysis with individual participant data (IPD). Addiction 2013;108:26–37. 10.1111/j.1360-0443.2012.04034.x. [PubMed: 22861822] [CrossRef]
20.
Taylor AH, Ussher MH, Faulkner G. The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction 2007;102:534–43. 10.1111/j.1360-0443.2006.01739.x. [PubMed: 17286639] [CrossRef]
21.
Taylor A, Katomeri M. Walking reduces cue-elicited cigarette cravings and withdrawal symptoms, and delays ad libitum smoking. Nicotine Tob Res 2007;9:1183–90. 10.1080/14622200701648896. [PubMed: 17978993] [CrossRef]
22.
Faulkner G, Arbour-Nicitopoulos KP, Hsin A. Cutting down one puff at a time: the acute effects of exercise on smoking behavior. J Smoking Cessation 2010;5:130–5. 10.1375/jsc.5.2.130. [CrossRef]
23.
Whiteley JA, Williams DM, Dunsiger S, Jennings EG, Ciccolo JT, Bock BC, et al. YMCA Commit to Quit: randomized trial outcomes. Am J Prev Med 2012;43:256–62. [PubMed: 22898118]
24.
Ussher MH, Taylor A, Faulkner G. Exercise interventions for smoking cessation. Cochrane Database Syst Rev 2012;1:CD002295. 10.1002/14651858.CD002295.pub2. [PubMed: 22258948] [CrossRef]
25.
Taylor AH, Ussher M. Physical activity as an aid to smoking cessation. In Ekkekakis P, editors. Handbook on Physical Activity and Mental Health. New York, NY: Routledge; 2013.
26.
Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 2012;345:e4439. 10.1136/bmj.e4439. [PMC free article: PMC3393785] [PubMed: 22782848] [CrossRef]
27.
Farley AC, Hajek P, Lycett D, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2012;1:CD006219. 10.1002/14651858.CD006219.pub3. [PubMed: 22258966] [CrossRef]
28.
Everson ES, Taylor AH, Ussher M, Faulkner G. A qualitative perspective on multiple health behaviour change: views of smoking cessation advisors who promote physical activity. J Smoking Cessation 2010;5:7–14. 10.1375/jsc.5.1.7. [CrossRef]
29.
Blundell JE, King NA. Exercise, appetite control, and energy balance. Nutrition 2000;16:519–22. 10.1016/S0899-9007(00)00250-1. [PubMed: 10906542] [CrossRef]
30.
Taylor AH. Physical activity and depression in obesity. In Bouchard C and Katzmarzyk PT, editors. Advances in Physical Activity and Obesity. 2nd edn. Champaign, IL: Human Kinetics; 2010. pp. 295–8.
31.
Lycett D, Munafo M, Johnstone E, Murphy M, Aveyard P. Weight change over eight years in relation to alcohol consumption in a cohort of continuing smokers and quitters. Nicotine Tob Res 2011;13:1149–54. 10.1093/ntr/ntr092. [PMC free article: PMC3203131] [PubMed: 21622496] [CrossRef]
32.
Aubin HJ, Rollema H, Svensson TH, Winterer G. Smoking, quitting, and psychiatric disease: a review. Neurosci Biobehav Rev 2012;36:271–84. 10.1016/j.neubiorev.2011.06.007. [PubMed: 21723317] [CrossRef]
33.
Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, et al. Exercise for depression. Cochrane Database Syst Rev 2013;9:CD004366. [PMC free article: PMC9721454] [PubMed: 24026850]
34.
Taylor AH. Physical activity, stress and anxiety: a review. In Biddle S, Boutcher S, Fox K, editors. Physical Activity and Psychological Well-being. London: Routledge; 2000.
35.
Van Rensburg KJ, Taylor A, Hodgson T. The effects of acute exercise on attentional bias towards smoking-related stimuli during temporary abstinence from smoking. Addiction 2009;104:1910–7. 10.1111/j.1360-0443.2009.02692.x. [PubMed: 19832788] [CrossRef]
36.
Janse Van Rensburg K, Taylor A, Benattayallah A, Hodgson T. The effects of exercise on cigarette cravings and brain activation in response to smoking-related images. Psychopharmacology 2012;221:659–66. 10.1007/s00213-011-2610-z. [PubMed: 22234380] [CrossRef]
37.
Verkooijen KT, Nielsen GA, Kremers SP. The association between leisure time physical activity and smoking in adolescence: an examination of potential mediating and moderating factors. Int J Behav Med 2008;15:157–63. 10.1080/10705500801929833. [PubMed: 18569134] [CrossRef]
38.
Kaczynski AT, Manske SR, Mannell RC, Grewal K. Smoking and physical activity: a systematic review. Am J Health Behav 2008;32:93–110. 10.5993/AJHB.32.1.9. [PubMed: 18021037] [CrossRef]
39.
Deruiter WK, Faulkner G, Cairney J, Veldhuizen S. Characteristics of physically active smokers and implications for harm reduction. Am J Public Health 2008;98:925–31. 10.2105/AJPH.2007.120469. [PMC free article: PMC2374828] [PubMed: 18381990] [CrossRef]
40.
Taylor AH, Doust J, Webborn N. Randomised controlled trial to examine the effects of a GP exercise referral programme in Hailsham, East Sussex, on modifiable coronary heart disease risk factors. J Epidemiol Community Health 1998;52:595–601. 10.1136/jech.52.9.595. [PMC free article: PMC1756762] [PubMed: 10320861] [CrossRef]
41.
Bull FC, Jamrozik K. Advice on exercise from a family physician can help sedentary patients to become active. Am J Prev Med 1998;15:85–94. 10.1016/S0749-3797(98)00040-3. [PubMed: 9713663] [CrossRef]
42.
Cerin E, Leslie E. How socio-economic status contributes to participation in leisure-time physical activity. Soc Sci Med 2008;66:2596–609. 10.1016/j.socscimed.2008.02.012. [PubMed: 18359137] [CrossRef]
43.
Cerin E, Leslie E, Owen N. Explaining socio-economic status differences in walking for transport: an ecological analysis of individual, social and environmental factors. Soc Sci Med 2009;68:1013–20. 10.1016/j.socscimed.2009.01.008. [PubMed: 19193480] [CrossRef]
44.
Cleland CL, Tully MA, Kee F, Cupples ME. The effectiveness of physical activity interventions in socio-economically disadvantaged communities: a systematic review. Prev Med 2012;54:371–80. 10.1016/j.ypmed.2012.04.004. [PubMed: 22521997] [CrossRef]
45.
Greaves CJ, Sheppard KE, Abraham C, Hardeman W, Roden M, Evans PH, et al. Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health 2011;11:119. 10.1186/1471-2458-11-119. [PMC free article: PMC3048531] [PubMed: 21333011] [CrossRef]
46.
Department of Health. Choosing health: making healthier choices easier. London: The Stationery Office; 2004.
47.
Carr SM, Lhussier M, Forster N, Geddes L, Deane K, Pennington M, et al. An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health. Health Technol Assess 2011;15(9). [PMC free article: PMC4781312] [PubMed: 21329611]
48.
Taylor AH, Everson-Hock ES, Ussher M. Integrating the promotion of physical activity within a smoking cessation programme: findings from collaborative action research in UK Stop Smoking Services. BMC Health Serv Res 2010;10:317. 10.1186/1472-6963-10-317. [PMC free article: PMC3001431] [PubMed: 21108797] [CrossRef]
49.
Koshy P, Mackenzie M, Leslie W, Lean M, Hankey C. Eating the elephant whole or in slices: views of participants in a smoking cessation intervention trial on multiple behaviour changes as sequential or concurrent tasks. BMC Public Health 2012;12:500. 10.1186/1471-2458-12-500. [PMC free article: PMC3416689] [PubMed: 22759785] [CrossRef]
50.
Miller WR. Motivational Interviewing with problem drinkers. Behav Psychother 1983;11:147–72. 10.1017/S0141347300006583. [CrossRef]
51.
Deci EL, Ryan RM. Intrinsic motivation and self-determination in human behavior. New York, NY: Plenum Press; 1985.
52.
Deci EL, Ryan RM. The what and why of human goal pursuits: human needs and the self-determination of behavior. Psychol Inq 2000;11:227–68. 10.1207/S15327965PLI1104_01. [CrossRef]
53.
Williams GC, McGregor HA, Sharp D, Levesque C, Kouides RW, Ryan RM, et al. Testing a self-determination theory intervention for motivating tobacco cessation: supporting autonomy and competence in a clinical trial. Health Psychol 2006;25:91–101. 10.1037/0278-6133.25.1.91. [PubMed: 16448302] [CrossRef]
54.
Vansteenkiste M, Sheldon KM. There’s nothing more practical than a good theory: integrating motivational interviewing and self-determination theory. Br J Clin Psychol 2006;45:63–82. 10.1348/014466505X34192. [PubMed: 16480567] [CrossRef]
55.
Markland D, Ryan RM, Tobin VJ, Rollnick S. Motivational interviewing and self-determination theory. J Social Clin Psychol 2005;24:811–31. 10.1521/jscp.2005.24.6.811. [CrossRef]
56.
Miller WR, Rollnick S. Meeting in the middle: motivational interviewing and self-determination theory. Int J Behav Nutr Phys Act 2012;9:25. 10.1186/1479-5868-9-25. [PMC free article: PMC3310779] [PubMed: 22385872] [CrossRef]
57.
Patrick H, Williams GC. Self-determination theory: its application to health behavior and complementarity with motivational interviewing. Int J Behav Nutr Phys Act 2012;9:18. 10.1186/1479-5868-9-18. [PMC free article: PMC3323356] [PubMed: 22385676] [CrossRef]
58.
Boardman T, Catley D, Grobe JE, Little TD, Ahluwalia JS. Using motivational interviewing with smokers: do therapist behaviors relate to engagement and therapeutic alliance? J Subst Abuse Treat 2006;31:329–39. 10.1016/j.jsat.2006.05.006. [PubMed: 17084786] [CrossRef]
59.
Draycott S, Dabbs A. Cognitive dissonance. 2: a theoretical grounding of motivational interviewing. Br J Clin Psychol 1998;37:355–64. 10.1111/j.2044-8260.1998.tb01391.x. [PubMed: 9784889] [CrossRef]
60.
Moyers TB, Martin T, Christopher PJ, Houck JM, Tonigan JS, Amrhein PC. Client language as a mediator of motivational interviewing efficacy: where is the evidence? Alcohol Clin Exp Res 2007;31:40s–7s. 10.1111/j.1530-0277.2007.00492.x. [PubMed: 17880345] [CrossRef]
61.
Smedslund G, Berg RC, Hammerstrom KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev 2011;5:CD008063. 10.1002/14651858.CD008063. [PMC free article: PMC8939890] [PubMed: 21563163] [CrossRef]
62.
Hettema JE, Hendricks PS. Motivational interviewing for smoking cessation: a meta-analytic review. J Consult Clin Psychol 2010;78:868–84. 10.1037/a0021498. [PubMed: 21114344] [CrossRef]
63.
Hardcastle S, Taylor AH, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet, and CHD risk factors. Patient Educ Couns 2008;70:31–9. 10.1016/j.pec.2007.09.014. [PubMed: 17997263] [CrossRef]
64.
Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
65.
Carver CS, Scheier MF. Control theory: a useful conceptual framework for personality-social, clinical, and health psychology. Psychol Bull 1982;92:111–35. 10.1037//0033-2909.92.1.111. [PubMed: 7134324] [CrossRef]
66.
Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390–5. 10.1037//0022-006X.51.3.390. [PubMed: 6863699] [CrossRef]
67.
Everson-Hock ES, Taylor AH, Ussher M. Readiness to use physical activity as a smoking cessation aid: a multiple behaviour change application of the transtheoretical model among quitters attending Stop Smoking Clinics. Patient Educ Couns 2010;79:156–9. 10.1016/j.pec.2009.09.016. [PubMed: 19818578] [CrossRef]
68.
Orbell S, Verplanken B. The automatic component of habit in health behavior: habit as cue-contingent automaticity. Health Psychol 2010;29:374–83. 10.1037/a0019596. [PubMed: 20658824] [CrossRef]
69.
Conklin CA. Environments as cues to smoke: implications for human extinction-based research and treatment. Exp Clin Psychopharmacol 2006;14:12–9. 10.1037/1064-1297.14.1.12. [PubMed: 16503701] [CrossRef]
70.
Lindson N, Aveyard P, Ingram JT, Inglis J, Beach J, West R, et al. Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial. Trials 2009;10:69. 10.1186/1745-6215-10-69. [PMC free article: PMC2739194] [PubMed: 19682359] [CrossRef]
71.
Ussher M, Cropley M, Playle S, Mohidin R, West R. Effect of isometric exercise and body scanning on cigarette cravings and withdrawal symptoms. Addiction 2009;104:1251–7. 10.1111/j.1360-0443.2009.02605.x. [PubMed: 19563567] [CrossRef]
72.
Bravata DM, Smith-Spangler C, Sundaram V, Gienger A, Lin N, Lewis R, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 2007;298:2296–304. 10.1001/jama.298.19.2296. [PubMed: 18029834] [CrossRef]
73.
Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol 2009;28:690–701. 10.1037/a0016136. [PubMed: 19916637] [CrossRef]
74.
Michie S, Hyder N, Walia A, West R. Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2011;36:315–9. 10.1016/j.addbeh.2010.11.016. [PubMed: 21215528] [CrossRef]
75.
Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health 2011;26:1479–98. 10.1080/08870446.2010.540664. [PubMed: 21678185] [CrossRef]
76.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694–6. 10.1136/bmj.321.7262.694. [PMC free article: PMC1118564] [PubMed: 10987780] [CrossRef]
77.
Murray RL, Bauld L, Hackshaw LE, McNeill A. Improving access to smoking cessation services for disadvantaged groups: a systematic review. J Public Health 2009;31:258–77. 10.1093/pubmed/fdp008. [PubMed: 19208688] [CrossRef]
78.
West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299–303. 10.1111/j.1360-0443.2004.00995.x. [PubMed: 15733243] [CrossRef]
79.
Blair SN, Haskell WL, Ho P, Paffenbarger RS Jr, Vranizan KM, Farquhar JW, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985;122:794–804. [PubMed: 3876763]
80.
Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res 1997;21:613–19. 10.1111/j.1530-0277.1997.tb03811.x. [PubMed: 9194913] [CrossRef]
81.
West RJ, Russell MA. Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms. Psychopharmacology 1985;87:334–6. 10.1007/BF00432717. [PubMed: 3936089] [CrossRef]
82.
West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology 2004;177:195–9. 10.1007/s00213-004-1923-6. [PubMed: 15179542] [CrossRef]
83.
Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010;8:13. 10.1186/1477-7525-8-13. [PMC free article: PMC2824714] [PubMed: 20109189] [CrossRef]
84.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119–27. 10.1111/j.1360-0443.1991.tb01879.x. [PubMed: 1932883] [CrossRef]
85.
Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 2012;14:75–8. [PubMed: 22025545]
86.
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385–96. 10.2307/2136404. [PubMed: 6668417] [CrossRef]
87.
Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav 2007;32:912–23. 10.1016/j.addbeh.2006.06.028. [PubMed: 16875787] [CrossRef]
88.
Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332. 10.1136/bmj.c332. [PMC free article: PMC2844940] [PubMed: 20332509] [CrossRef]
89.
Laugesen M, Epton M, Frampton CM, Glover M, Lea RA. Hand-rolled cigarette smoking patterns compared with factory-made cigarette smoking in New Zealand men. BMC Public Health 2009;9:194. 10.1186/1471-2458-9-194. [PMC free article: PMC2711947] [PubMed: 19538719] [CrossRef]
90.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. 10.1136/bmj.a1655. [PMC free article: PMC2769032] [PubMed: 18824488] [CrossRef]
91.
Moyers TB, Martin T, Houck JM, Christopher PJ, Tonigan JS. From in-session behaviors to drinking outcomes: a causal chain for motivational interviewing. J Consult Clin Psychol 2009;77:1113–24. 10.1037/a0017189. [PMC free article: PMC2819223] [PubMed: 19968387] [CrossRef]
92.
Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol 2004;23:443–51. 10.1037/0278-6133.23.5.443. [PubMed: 15367063] [CrossRef]
93.
Denford S, Campbell JL, Frost J, Greaves CJ. A qualitative exploration of processes of change in an asthma self-care intervention. Qual Health Res 2013;23:1419–29. [PubMed: 24062418]
94.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. 10.1016/j.ijnurstu.2012.09.010. [PMC free article: PMC2769032] [PubMed: 18824488] [CrossRef]
95.
Dreyfus HL. The Dreyfus model of skill acquisition. In Burke J, editor. Competency Based Education and Training. London: Falmer Press; 1989.
96.
Ritchie JL, Spencer L. Qualitative data analysis for applied policy research. In Bryman A, Burgess R, editors. Analyzing Qualitative Data. London: Routledge; 1994. pp. 173–94.
97.
Curtis L. Unit Costs of Health and Social Care 2011. Canterbury: PSSRU, University of Kent: 2011.
98.
Glick H. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press; 2007.
99.
Bolin K. Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models. Pharmacoeconomics 2012;30:551–64. 10.2165/11590120-000000000-00000. [PubMed: 22591112] [CrossRef]
100.
Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002;6(16). [PubMed: 12269277]
101.
Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis. Health Technol Assess 2010;14(49). [PubMed: 21040645]
102.
Howard P, Knight C, Boler A, Baker C. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. Pharmacoeconomics 2008;26:497–511. 10.2165/00019053-200826060-00004. [PubMed: 18489200] [CrossRef]
103.
Ronckers ET, Groot W, Ament AJ. Systematic review of economic evaluations of smoking cessation: standardizing the cost-effectiveness. Med Decis Making 2005;25:437–48. 10.1177/0272989X05278431. [PubMed: 16061896] [CrossRef]
104.
Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Molken MP. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 2005;8:178–90. 10.1111/j.1524-4733.2005.04008.x. [PubMed: 15877590] [CrossRef]
105.
Hurley SF, Matthews JP. The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Eff Resour Alloc 2007;5:2. [PMC free article: PMC1796848] [PubMed: 17241477]
106.
Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians’ smoking cessation counseling. JAMA 1996;275:1247–51. 10.1001/jama.1996.03530400035035. [PubMed: 8601956] [CrossRef]
107.
Orme ME, Hogue SL, Kennedy LM, Paine AC, Godfrey C. Development of the health and economic consequences of smoking interactive model. Tob Control 2001;10:55–61. 10.1136/tc.10.1.55. [PMC free article: PMC1763982] [PubMed: 11226362] [CrossRef]
108.
Godfrey C, Parrott S, Coleman T, Pound E. The cost-effectiveness of the English smoking treatment services: evidence from practice. Addiction 2005;100(Suppl. 2):70–83. 10.1111/j.1360-0443.2005.01071.x. [PubMed: 15844290] [CrossRef]
109.
National Institute for Health and Care Excellence. PH1: Brief Interventions and Referral for Smoking Cessation. 2006. URL: www​.nice.org.uk/guidance/PH1/guidance (accessed 8 November 2013).
110.
Bauld L, Boyd KA, Briggs AH, Chesterman J, Ferguson J, Judge K, et al. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res 2011;13:135–45. 10.1093/ntr/ntq222. [PubMed: 21196451] [CrossRef]
111.
Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994;309:901–11. 10.1136/bmj.309.6959.901. [PMC free article: PMC2541142] [PubMed: 7755693] [CrossRef]
112.
Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA 2000;284:706–12. 10.1001/jama.284.6.706. [PubMed: 10927778] [CrossRef]
113.
Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519. 10.1136/bmj.38142.554479.AE. [PMC free article: PMC437139] [PubMed: 15213107] [CrossRef]
114.
Mahmoudi M, Coleman CI, Sobieraj DM. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation. Int J Clin Pract 2012;66:171–82. 10.1111/j.1742-1241.2011.02877.x. [PubMed: 22257042] [CrossRef]
115.
Knight C, Howard P, Baker CL, Marton JP. The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. Value Health 2010;13:209–14. 10.1111/j.1524-4733.2009.00672.x. [PubMed: 19912599] [CrossRef]
116.
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005;2:CD001007. 10.1002/14651858.CD001007. [PubMed: 15846610] [CrossRef]
117.
Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 2003;327:28–9. 10.1136/bmj.327.7405.28. [PMC free article: PMC164239] [PubMed: 12842953] [CrossRef]
118.
Curtis L. Unit Costs of Health and Social Care 2005. Canterbury: PSSRU, University of Kent; 2005.
119.
Department of Health. Health Survey for England 2004. London: The Stationery Office; 2006.
120.
Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000;38:583–637. 10.1097/00005650-200006000-00004. [PubMed: 10843310] [CrossRef]
121.
Etter JF, Stapleton JA. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006;15:280–5. 10.1136/tc.2005.015487. [PMC free article: PMC2563611] [PubMed: 16885576] [CrossRef]
122.
Wetter DW, Cofta-Gunn L, Fouladi RT, Cinciripini PM, Sui D, Gritz ER. Late relapse/sustained abstinence among former smokers: a longitudinal study. Prev Med 2004;39:1156–63. 10.1016/j.ypmed.2004.04.028. [PubMed: 15539050] [CrossRef]
123.
Krall EA, Garvey AJ, Garcia RI. Smoking relapse after 2 years of abstinence: findings from the VA Normative Aging Study. Nicotine Tob Res 2002;4:95–100. 10.1080/14622200110098428. [PubMed: 11906685] [CrossRef]
124.
Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. Centre for Health Economics discussion paper 172. York: Centre for Health Economics, University of York; 1999.
125.
Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA. Burden of smoking on cause-specific mortality: application to the Nurses’ Health Study. Tob Control 2010;19:248–54. 10.1136/tc.2009.032839. [PMC free article: PMC3050007] [PubMed: 20501499] [CrossRef]
126.
Vogl M, Wenig CM, Leidl R, Pokhrel S. Smoking and health-related quality of life in English general population: implications for economic evaluations. BMC Public Health 2012;12:203. 10.1186/1471-2458-12-203. [PMC free article: PMC3352300] [PubMed: 22429454] [CrossRef]
127.
Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N Engl J Med 1997;337:1052–7. 10.1056/NEJM199710093371506. [PubMed: 9321534] [CrossRef]
128.
Nyman JA. Should the consumption of survivors be included as a cost in cost-utility analysis? Health Econ 2004;13:417–27. 10.1002/hec.850. [PubMed: 15127422] [CrossRef]
129.
NICE. Guide to the Methods of Technology Appraisal. London: NICE; 2008. URL: www​.nice.org.uk/niceMedia​/pdf/TAP_Methods.pdf (accessed 22 November 2012).
130.
Briggs AH, Claxton K, Sculpher MJ. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
131.
Drummond MF. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford: Oxford University Press; 2005.
132.
Great Britain. Health and Social Care Act 2012. London: The Stationery Office; 2012.